Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens | Zendy

Justin de la Cruz | Zendy; Saran Vardhanbhuti | Zendy; Malaya K. Sahoo | Zendy; Robert Rovner | Zendy; Ronald J. Bosch | Zendy; Justen Manasa | Zendy; David Katzenstein | Zendy; Benjamin A. Pinsky | Zendy

Open Access

Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens

Author(s) -

Justin de la Cruz,

Saran Vardhanbhuti,

Malaya K. Sahoo,

Robert Rovner,

Ronald J. Bosch,

Justen Manasa,

David Katzenstein,

Benjamin A. Pinsky

Publication year - 2019

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofz034

Subject(s) - efavirenz , virology , persistence (discontinuity) , medicine , human immunodeficiency virus (hiv) , antiretroviral drug , drug resistance , antiretroviral therapy , viral load , biology , microbiology and biotechnology , geotechnical engineering , engineering

Persistence of RTI mutations in proviral DNA after virologic failure has implications for the effectiveness of future drug regimens and the recycling of RTI drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research